在查加斯病中,大脑天然尿素和左室功能障碍在查加斯病中
Antonio Luiz P Ribeiro1, Adelina Martha dos Reis, Marcio Vinicius L Barros
1Postgraduate Course of Tropical Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil. tom@hc.ufmb.br
Lancet (London, England)
|September 21, 2002
概括
血大脑尿性 (BNP) 可以有效地选沙加斯病患者的左心室功能障碍. 60.7 pmol/L或更高的BNP水平可以识别需要进一步评估的人,有助于早期干预.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 生物标志物 生物标志物
背景情况:
- 左心室功能障碍是查加斯病的常见并发症.
- 早期发现心脏干扰对于及时治疗和改善预后至关重要.
- 目前的诊断方法可能并不总是足以识别所有受影响的个体.
研究的目的:
- 评估血大脑性尿素 (BNP) 测量在查加斯病中检测左心室功能障碍时的效用.
- 确定最佳的BNP度值,以识别需要进一步调查或治疗的患者.
主要方法:
- 这项研究包括患有夏加斯病和心电图或胸部X射线图异常发现的患者.
- 测量了血中的BNP度.
- 敏感度,特异性和预测值为特定的BNP值计算.
主要成果:
- 血BNP度为60.7 pmol/L或更高表明了高的诊断准确性.
- 门达到80%的灵敏度和97%的特异性,用于检测左心室功能障碍.
- 积极和消极的预测值分别为80%和97%.
结论:
- 血BNP测量是一种有价值和可访问的工具,用于查查加斯病患者的左心室功能障碍.
- 这种生物标志物可以帮助识别那些可以从进一步的心脏评估和管理中受益的人.
- 通过BNP测试,可以简化查加斯病心肌病的诊断途径.
相关概念视频
Transcellular Transport of Solutes
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
Physiology of Urine Formation
Urine formation is an essential function of the human body. It plays a critical role in maintaining homeostasis by regulating the volume and composition of body fluids. The kidneys, the primary organs involved in this process, filter blood to remove waste products and excess substances, ultimately producing urine.
Glomerular Filtration
The first stage in urine formation is glomerular filtration. Each kidney contains approximately 1 million nephrons, the functional units of filtration, with a...
Glomerular Filtration
The first stage in urine formation is glomerular filtration. Each kidney contains approximately 1 million nephrons, the functional units of filtration, with a...
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cerebral Edema l: Introduction
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


